The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Machine Learning for Drug-Target Interaction Prediction
Open accessAbstract
Identifying drug-target interactions will greatly narrow down the scope of search of candidate medications, and thus can serve as the vital first step in drug discovery. Considering that in vitro experiments are extremely costly and time-consuming, high efficiency computational prediction methods could serve as promising strategies for drug-target interaction (DTI) prediction. In this review, our goal is to focus on machine learning approaches and provide a comprehensive overview. First, we summarize a brief list of databases frequently used in drug discovery. Next, we adopt a hierarchical classification scheme and introduce several representative methods of each category, especially the recent state-of-the-art methods. In addition, we compare the advantages and limitations of methods in each category. Lastly, we discuss the remaining challenges and future outlook of machine learning in DTI prediction. This article may provide a reference and tutorial insights on machine learning-based DTI prediction for future researchers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Different algorithms based on AI, including supervised and unsupervised learning methods, reinforcement, and evolutionary or rule-based algorithms, can potentially contribute to solving these problems.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An introduction to ROC analysis
Fawcett, T. (2006) · Pattern Recognition Letters · doi:10.1016/j.patrec.2005.10.010 · Cited by 21,879
No free lunch theorems for optimization
Wolpert, D. H., & Macready, W. G. (1997) · IEEE Transactions on Evolutionary Computation · doi:10.1109/4235.585893 · Cited by 14,237
A Global Geometric Framework for Nonlinear Dimensionality Reduction
Tenenbaum, J. B., Silva, V. D., & Langford, J. C. (2000) · Science · doi:10.1126/science.290.5500.2319 · Cited by 13,585
KEGG: new perspectives on genomes, pathways, diseases and drugs
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1092 · Cited by 8,865
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
The relationship between Precision-Recall and ROC curves
Davis, J., & Goadrich, M. (2006) · Proceedings of the 23rd international conference on Machine learning - ICML '06 · doi:10.1145/1143844.1143874 · Cited by 6,559
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,185
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Bork, P., & Kuhn, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1277 · Cited by 1,740
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. I. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,148
Next-Generation Machine Learning for Biological Networks
Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018) · Cell · doi:10.1016/j.cell.2018.05.015 · Cited by 1,012
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 943
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 926
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lü, W., Li, W., Liu, G., Zhou, W., Huang, J. Y., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 827
Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulytė, A., Shoemaker, B. A., Thiessen, P. A., He, S., & Zhang, J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1118 · Cited by 675
Drug–target interaction prediction: databases, web servers and computational models
Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbv066 · Cited by 658
SuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647 · cited 1×
“MATADOR [37] http://matador.embl.de/ A database of protein-chemical interactions including as many direct and indirect interactions as possible.”
BackgroundSupervised prediction of drug–target interactions using bipartite local models
Kevin Bleakley, A., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 638
SuperPred: update on drug classification and target prediction
Nickel, J., Gohlke, B.-O., Erehman, J., Banerjee, P., Rong, W. W., Goede, A., Dunkel, M., & Preißner, R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku477 · Cited by 591
Toward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietilä, S., Shakyawar, S. K., Szwajda, A., Tang, J. P., & Aittokallio, T. A. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 587
A survey of current trends in computational drug repositioning
Li, J., Zheng, S., Chen, B., Butte, A. J., Swamidass, S. J., & Lu, Z. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv020 · Cited by 569
Key factors in the rising cost of new drug discovery and development
Dickson, M., & Gagnon, J. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1382 · Cited by 507
Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm
Luo, H., Wang, J., Li, M., Luo, J., Peng, X., Wu, F., & Pan, Y. F. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw228 · Cited by 479
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 430
Yu, H., Chen, M., Xu, X. J., Li, Y., Zhao, H., Fang, Y., Li, X., Zhou, W., Wang, W., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037608 · Cited by 426
Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces
Xia, Z., Wu, L., Zhou, X., & Wong, S. T. C. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s6 · Cited by 397
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X., & Zheng, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 386
Gönen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts360 · Cited by 383
Wan, F., Hong, L., Xiao, A., Jiang, T., & Zeng, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty543 · Cited by 381
Zhang, W., Chen, Y., Liu, F., Luo, F., Tian, G., & Li, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1415-9 · Cited by 357
A comprehensive overview and evaluation of circular RNA detection tools
Zeng, X., Lin, W., Guo, M., & Zou, Q. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005420 · Cited by 347
Zheng, X., Ding, H., Mamitsuka, H., & Zhu, S. (2013) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/2487575.2487670 · Cited by 335
Zeng, X., Zhang, X., & Zou, Q. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv033 · Cited by 325
Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization
Ezzat, A., Zhao, P., Wu, M., Li, X., & Kwoh, C.-K. (2016) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2530062 · Cited by 322
Ezzat, A., Wu, M., Li, X., & Kwoh, C. K. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby002 · Cited by 321
ChemBank: a small-molecule screening and cheminformatics resource database
Seiler, K. P., George, G. A., Happ, M. P., Bodycombe, N. E., Carrinski, H. A., Norton, S., Brudz, S., Sullivan, J. P., Muhlich, J. L., Serrano, M., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm843 · Cited by 283
BRENDA in 2017: new perspectives and new tools in BRENDA
Placzek, S., Schomburg, I., Chang, A., Jeske, L., Ulbrich, M., Tillack, J., & Schomburg, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw952 · Cited by 274
Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile
van Laarhoven, T., & Marchiori, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066952 · Cited by 249
Label Propagation Prediction of Drug-Drug Interactions Based on Clinical Side Effects
Zhang, P., Wang, F., Hu, J., & Sorrentino, R. (2015) · Scientific Reports · doi:10.1038/srep12339 · Cited by 242
Prediction of potential disease-associated microRNAs using structural perturbation method
Zeng, X., Liu, L., Lü, L., & Zou, Q. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty112 · Cited by 235
Drug Similarity Integration Through Attentive Multi-view Graph Auto-Encoders
Ma, T., Xiao, C., Zhou, J., & Wang, F. (2018) · Proceedings of the Twenty-Seventh International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/483 · Cited by 220
SuperTarget goes quantitative: update on drug-target interactions
Hecker, N., Ahmed, J., von Eichborn, J., Dunkel, M., Macha, K., Eckert, A. P., Gilson, M. K., Bourne, P. E., & Preißner, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr912 · Cited by 218
Predicting drug-target interactions using restricted Boltzmann machines
Wang, Y., & Zeng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt234 · Cited by 210
Prediction and Validation of Disease Genes Using HeteSim Scores
Zeng, X., Liao, Y., Liu, Y., & Zou, Q. (2017) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2016.2520947 · Cited by 208
Zong, N., Kim, H., Ngo, V., & Harismendy, O. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx160 · Cited by 190
Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization
Çobanoğlu, M. C., Liu, C., Hu, F., Oltvai, Z. N., & Bahar, İ. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400219z · Cited by 189
Predicting potential side effects of drugs by recommender methods and ensemble learning
Zhang, W., Zou, H., Luo, L., Liu, Q., Wu, W., & Xiao, W. (2015) · Neurocomputing · doi:10.1016/j.neucom.2015.08.054 · Cited by 147
Predicting drug target interactions using meta-path-based semantic network analysis
Fu, G., Ding, Y., Seal, A., Chen, B., Sun, Y., & Bolton, E. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1005-x · Cited by 143
TDR Targets: a chemogenomics resource for neglected diseases
Magariños, M. P., Carmona, S. J., Crowther, G. J., Ralph, S. A., Roos, D. S., Shanmugam, D., A, W. C. V. V., & Agüero, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1053 · Cited by 132
Drug-target interaction prediction via class imbalance-aware ensemble learning
Ezzat, A., Wu, M., Li, X., & Kwoh, C. K. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1377-y · Cited by 131
Meta-Path Methods for Prioritizing Candidate Disease miRNAs
Zhang, X., Zou, Q., Rodríguez‐Patón, A., & Zeng, X. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2776280 · Cited by 130
CancerDR: Cancer Drug Resistance Database
Kumar, R., Chaudhary, K., Gupta, S., Singh, H., Kumar, S., Gautam, A., Kapoor, P., & Raghava, G. P. S. (2013) · Scientific Reports · doi:10.1038/srep01445 · Cited by 129
Protein Folds Prediction with Hierarchical Structured SVM
Li, D., Ju, Y., & Zou, Q. (2016) · Current Proteomics · doi:10.2174/157016461302160514000940 · Cited by 125
DCDB 2.0: a major update of the drug combination database
Liu, Y., Wei, Q., Yu, G., Gai, W., Li, Y., & Chen, X. (2014) · Database · doi:10.1093/database/bau124 · Cited by 123
Therapeutic target database update 2014: a resource for targeted therapeutics
Chu, Q., Zhang, C., Zhu, F., Xu, F., Chen, S. Y., Zhang, P., Li, Y., Yang, S. Y., Wei, Y., Tao, L., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1129 · Cited by 122
A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks
Chen, H., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062975 · Cited by 120
Nagamine, N., & Sakakibara, Y. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm266 · Cited by 116
Protein-ligand Docking: A Review of Recent Advances and Future Perspectives
Pujadas, G., Vaqué, M., Ardèvol, A., Bladé, C., Salvadó, M. J., Blay, M., Fernández-Larrea, J., & Arola, L. (2008) · Current Pharmaceutical Analysis · doi:10.2174/157341208783497597 · Cited by 106
Drug-target interaction prediction using ensemble learning and dimensionality reduction
Ezzat, A., Wu, M., Li, X., & Kwoh, C.-K. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.016 · Cited by 106
Drug–target interaction prediction via chemogenomic space: learning-based methods
Mousavian, Z., & Masoudi‐Nejad, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.950222 · Cited by 102
ASDCD: Antifungal Synergistic Drug Combination Database
Chen, X., Ren, B., Chen, M., Liu, M.-X., Ren, W., Wang, Q., Zhang, L., & Yan, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086499 · Cited by 88
Drug-target and disease networks: polypharmacology in the post-genomic era
Masoudi‐Nejad, A., Mousavian, Z., & Bozorgmehr, J. H. (2013) · In Silico Pharmacology · doi:10.1186/2193-9616-1-17 · Cited by 83
An Empirical Study of Features Fusion Techniques for Protein-Protein Interaction Prediction
Zeng, J., Li, D., Wu, Y., Zou, Q., & Liu, X. (2015) · Current Bioinformatics · doi:10.2174/1574893611666151119221435 · Cited by 55
Self-citationChemogenomic Approaches to Infer Drug–Target Interaction Networks
Yamanishi, Y. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-107-3_9 · Cited by 50
Review of Protein Subcellular Localization Prediction
Wang, Z., Zou, Q., Jiang, Y., Ju, Y., & Zeng, X. (2014) · Current Bioinformatics · doi:10.2174/1574893609666140212000304 · Cited by 43
Wan, F., Hong, L., Xiao, A., Jiang, T., & Zeng, J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/261396 · Cited by 34
SRP: A concise non-parametric similarity-rank-based model for predicting drug-target interactions
Shi, J., & Yiu, S. (2015) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2015.7359921 · Cited by 29
A Discussion of MicroRNAs in Cancers
Shi, H. W., Yun, W., Zhiqiang, Z., & Zou, Q. (2014) · Current Bioinformatics · doi:10.2174/1574893609666140804221135 · Cited by 26
An Ensemble Learning Approach for Improving Drug–Target Interactions Prediction
Zhang, R. (2015) · Lecture notes in electrical engineering · doi:10.1007/978-3-319-11104-9_51 · Cited by 12
A Classification Method for Microarrays Based on Diversity
Wang, X., Zeng, X., Ju, Y., Jiang, Y. H., Zhang, Z., & Chen, W. (2016) · Current Bioinformatics · doi:10.2174/1574893609666140820224436 · Cited by 8
Cited by
Sorted by citations
The role of AI in drug discovery: challenges, opportunities, and strategies
Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Maia, E. H. B., de Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00343 · Cited by 623
Exploiting machine learning for end-to-end drug discovery and development
Ekins, S., Puhl, A. C., Zorn, K. M., Lane, T. R., Russo, D. P., Klein, J. J., Hickey, A. J., & Clark, A. M. (2019) · Nature Materials · doi:10.1038/s41563-019-0338-z · Cited by 578
A review on machine learning approaches and trends in drug discovery
Carracedo-Reboredo, P., Liñares-Blanco, J., Rodríguez-Fernández, N., Cedrón, F., Novoa, F. J., Carballal, A., Maojo, V., Pazos, A., & Fernandez-Lozano, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.011 · Cited by 517
Machine Learning Methods in Drug Discovery
Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020) · Molecules · doi:10.3390/molecules25225277 · Cited by 460
Metadata
- Authors
- Chen, R., Liu, X., Jin, S., Lin, J., & Liu, J.
- Affiliations
- Xiamen University (CN)
- Corresponding author
- Liu, Juan
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-08-31
- Volume
- 23
- Issue
- 9
- Pages
- 2208
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6225477
- OpenAlex
- W2889321024
- Cited by
- 292
- References
- 74
- Citations by year
- 2026: 22 · 2025: 34 · 2024: 56 · 2023: 44 · 2022: 49 · 2021: 41 · 2020: 24 · 2019: 22
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (61472333, 61772441, 61472335)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- drug-target interaction prediction, machine learning, drug discovery, hierarchical classification, computational drug discovery
- MeSH terms
- Machine Learning, Algorithms, Drug Interactions, Humans, Drug Delivery Systems, Databases as Topic, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
